Dr Ranjan Rajesh Bera, PHARM D - Pharmacist in Corona, CA

Dr Ranjan Rajesh Bera, PHARM D is a Pharmacist based in Corona, California. Dr Ranjan Rajesh Bera is licensed to practice in California (license number RPH39640) and her current practice location is 7819 Sanctuary Dr, Corona, California. She can be reached at her office (for appointments etc.) via phone at (951) 277-7839.

NPI number for Dr Ranjan Rajesh Bera is 1003988056 and her current mailing address is 7819 Sanctuary Dr, Corona, California. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1003988056.

Contact Information

Dr Ranjan Rajesh Bera, PHARM D
7819 Sanctuary Dr,
Corona, CA 92883-5949
(951) 277-7839
Not Available

Healthcare Provider's Profile

Full NameDr Ranjan Rajesh Bera
GenderFemale
SpecialityPharmacist
Location7819 Sanctuary Dr, Corona, California
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1003988056
  • Provider Enumeration Date: 11/14/2006
  • Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Dr Ranjan Rajesh Bera such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1003988056NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
183500000XPharmacist RPH39640 (California)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Ranjan Rajesh Bera is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Ranjan Rajesh Bera, PHARM D
7819 Sanctuary Dr,
Corona, CA 92883-5949

Ph: (951) 277-7839
Dr Ranjan Rajesh Bera, PHARM D
7819 Sanctuary Dr,
Corona, CA 92883-5949

Ph: (951) 277-7839

News Archive

Australia's Mesoblast receives nod to start first European trial of allogeneic stem cell treatment for heart attacks

Global regenerative medicine company, Mesoblast Limited, (ASX: MSB), today announced that it had received clearance from the European Medicines Agency (EMA) to begin a 225-patient multi-center Phase 2 clinical trial in Europe for its lead cardiovascular product Revascorâ„¢ in conjunction with angioplasty and stent procedures to prevent heart failure after a major heart attack. Revascorâ„¢ is an allogeneic, or "off-the-shelf", adult stem cell product derived from Mesoblast's proprietary Mesenchymal Precursor Cell (MPC) platform technology which is being developed for use in a range of cardiovascular diseases including congestive heart failure, chronic angina, and heart attacks (acute myocardial infarction).

Experimental treatment shrinks rare pediatric tumor by 90%

When a baby's life was threatened by a rare pediatric cancer that would not respond to surgery or chemotherapy, doctors at Nemours Children's Hospital rapidly, successfully shrank the tumor by 90 percent using an experimental treatment, according to a new study published online in Pediatric Blood and Cancer.

New study correlates 80 cancer-related gene mutations with 34 AML subgroups

A large, new study of adults with acute myeloid leukemia (AML) correlates 80 cancer-related gene mutations with five subtypes of AML, which are defined by the presence of specific chromosomal abnormalities. The findings might help guide mutation testing and treatment decisions in the future.

Autism Speaks' affiliate DELSIA announces new funding for clinical trial of cognitive video game

Autism Speaks' not-for-profit affiliate Delivering Scientific Innovation for Autism has announced new funding for clinical testing of a cognitive video game designed to improve executive function skills in children and adolescents with autism.

Read more News

› Verified 6 days ago


Pharmacist in Corona, CA

Dr. Moderne Young, PHARMD
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 2055 Kellogg Ave, Corona, CA 92879
Phone: 951-898-7106    
Linh Phan Thuy Nguyen,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 1107 W 6th St, Corona, CA 92882
Phone: 951-520-9700    
Diana Zen, PHARM.D.
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 420 N Main St Ste 105, Corona, CA 92880
Phone: 951-475-7870    
Tran Pham, PHARMD
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 1322 W 6th St, Corona, CA 92882
Phone: 951-817-8636    
Mr. Richard Joon Kim, PHARMD
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 4315 Driving Range Rd, Corona, CA 92883
Phone: 805-404-5358    
Mr. Ernest M Liu, PHARM.D.
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 221 E 3rd St, Corona, CA 92879
Phone: 951-735-4600    Fax: 951-284-4701

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.